Overview of events

You can find all health policy events over the course of Germany’s Presidency of the Council of the European Union that concern the Federal Ministry of Health, its remit and the associated programme in our Events Calendar. Please note that some events are reserved for specific specialist groups and are not open to the general public.

Disclaimer in light of the current situation

Due to the COVID-19 pandemic, changes to events within the framework of Germany’s Presidency or their format may arise at short notice. All entries in the calendar are therefore subject to change.

Institutional programme online

Meeting of the Expert of European Medicines Agencies Co-operation of Legal and Legislative Issues (EMACOLEX)

EMACOLEX (European Medicines Agencies Cooperation on Legal and Legislative Issues) is an informal working group set up by the Heads of Medicines Agencies (HMA) to promote the cooperation on legal matters among lawyers working in European licensing authorities.

EMACOLEX supports the efforts of the European Medicines Regulatory Network (EMRN) to safeguard public and animal health protection by providing a dialogue and discussion platform for lawyers and other staff of licensing authorities involved in legal matters.

EMACOLEX aims to ensure legal assistance to the EMRN and the individual competent national authorities. EMACOLEX is chaired by the current Presidency.

This event is non-puplic and organized by the Federal Institute for Drugs and Medical Devices.

More Information: Heads of Medicines Agencies (HMA)

Events MoH online

Meeting of Directors for Pharmaceutical Policy of the European Health Ministries

Meeting of the directors for pharmaceutical policy of the European health ministries to discuss and align ideas to advance public health.

Events MoH online

Meeting of the Network of Competent Authorities for Pricing and Reimbursement : New gene therapies and real world evidence – how can we make best use of it?

The objective of this meeting is to discuss the significance of real world evidence in the (benefit) assessment of gene therapies and the connection with innovative reimbursement schemes. It will focus on identifying potential similarities with the marketing authorisation process of the European Medicines Agency (EMA) to initiate early on long-term cooperation between EMA and the health technology assessment (HTA) institutions with regard to data requirements.

This is a non-public event.

Events MoH presence

Interprofessional collaboration in healthcare

Interprofessional collaboration in healthcare is a topic that must be considered throughout Europe, because even though health care is a core national task, the Member States of the EU face similar challenges. Care provision structures are constantly becoming more professional and complex, yet, despite digitalisation and technology, this does not lead to a reduction in the number of health care tasks. Additionally, many healthcare professions are already experiencing a shortage of skilled personnel. Interprofessional collaboration is the only way to successfully provide health care. Here, clear differences exist between the different EU Member States. This event will take a look at other EU countries and find out what we can learn from one another.

This is a non-public event.

Associated programme online

Health Innovation – the European Health Data Space and Real-World Evidence

The COVID-19 pandemic shows that real-world evidence generation has become even more crucial as data collected in medical practice would not only inform health systems and their resources, but also inform the development of medicines for the benefit of patients. The EU’s data strategy and proposed creation of a European Health Data Space offer the opportunity to harness the potential of real-world data through cross border collaboration with a view to enabling sustainable and early patient access to innovative technologies. This approach is also particularly relevant in view of the EU’s commitment to the Beating Cancer Plan. This Conference will consider how a multi-stakeholder EU Learning Network could be established to foster learnings from the use of real-world evidence within the context of the European Health Data Space in order to inform deliberations between payers/HTA authorities and enable a learning system to bring the right treatment, for the right patient, at the right time. #rwe4decisions

This event is public and organised by the Multi-Stakeholder Group RWE4Decisions.

Contact: RWE4Decisions Secretariat, secretariat@rwe4decisions(dot)com

More Information: RWE4Decisions

Events MoH presence

High-Level Conference "Digital Health 2020 – EU on the Move"

The High-Level Conference "Digital Health 2020 – EU on the Move" aims to advance a topic that is central to shaping our future: ensuring the science-based, legally sound and values-based use of big data and artificial intelligence as a foundation for providing healthcare to the European citizens. As an economic, scientific and values-based community, the European Union advocates a sensitive and patient-oriented use of health data. The handling of health data in the context of pandemic incidents is also to be discussed. The conference will bring together up to 450 invit-ed decision-makers from politics, science, business, medicine and civil society and, with its innovative formats, should provide a place of communication and exchange on how best to attain a joint EU health data space. Selected items of the programme will be published via stream.

Contact: Ministry of Health, EU2020@bmg.bund(dot)de

Events MoH presence

Meeting of the european eHealth Network

The objectives of the eHealth network according to Article 14 of the EU Patient Mobility Directive is to work towards delivering sustainable economic and social benefits of European eHealth systems and services and interoperable applications, with a view to achieving a high level of trust and security, enhancing continuity of care and ensuring access to safe and high-quality healthcare. The eHealth Network is thus a central platform for cooperation on digital health at EU level, contributing to the European health data space and also undertaking important work to align digital solutions in fighting the Covid-19 pandemic.

This is a non-public event.

More Information: eHealth Network

Associated programme hybrid

Doctors going digital: How to future-proof skills

What digital skills and abilities does the physician need in light of the increasing prevalence of telemedicine apps or the use of artificial intelligence in medicine? To tie in with Germany’s presidency of the Council of the European Union, the physicians’ organisations that comprise the Standing Committee of European Doctors (CPME) and the German Medical Association, along with an audience of experts, would like to address the question of what digital skills the physician must have in order to be able to safely make use of the possibilities offered by new technology in a way that benefits the patient. Related to this is also the question of how to impart the corresponding skills and abilities when faced with medical degree courses that are already condensed or in the case of doctors who are already practising medicine. The conference will take place on 20 November 2020 from 09:00 to 12:00 in Berlin. #CPMEdigitalskills

This event is public and organised by the German Medical Association (BÄK) and the Standing Commitee of European Doctors (CPME).

More Information: Bundesärztekammer

Contact: international@baek(dot)de

Associated programme online

Digital Health: NOW! Acting jointly for a digitised and value-based healthcare in the EU

Demographic development, structural factors, personnel shortage: The healthcare system in the EU faces major challenges. At the same time, the digitisation of society changes citizens’ expectations of modern care creating new opportunities for a healthcare system that is interconnected and digitally supported. The handling of the COVID-19 pandemic has shown how important it is to ensure a rapid transition to shared health care systems. Alternatives for face-to-face diagnoses and therapies had to be developed quickly. Many solutions have made it clear that digital medicine (i.e. telemedicine, interconnectedness, automatic integration and AI-supported use of data) enhances and strengthens healthcare. The highest level of medical expertise and cross-border cooperation in care must be available in every part of Europe. The overarching goal is a value-based healthcare system for every citizen in the EU. #digitalhealthNowEU

This event is public and organised by German Telemedicine Association (DGTelemed), the Innovation Center Digital Medicine at the Uniklinik RWTH Aachen (IZDM) and the ZTG Centre for eHealth and Telemedicine.

More Information: Digital Health NOW 2020

Contact: Anna Wewer, info@digitalhealth-now(dot)eu

Institutional programme online

HMA Working Group of Quality Managers (WGQM) Meeting

The HMA Working Group of Quality Managers (WGQM) is a working group of quality managers of the national competent authorities who are responsible for the regulation of medicinal products for human in the European Economic Area. They meet biannually for an exchange on quality assurance measures with respect to official working procedures and to steer and promote benchmarking procedures.

This event is  non-puplic and organized by the Federal Institute for Vaccines and Biomedicines.

Associated programme hybrid

Personalised medicine in oncology: Benefits for cancer patients, society and health systems in Germany and Europe

Together with the European Commission and the initiative Europe’s Beating Cancer Plan, Germany would like to use its Council Presidency to drive forward the fight against cancer in Europe. The aim of the event is not only to continuously raise awareness of medical progress in the area of oncology, but also to engage in a dialogue about the ways in which innovation is received in the everyday life of patients and how healthcare systems can cope with it. Using practical examples, innovative therapeutic options in oncology will be presented and then the added value for society as well as the associated challenges will be discussed.

This event is public and organised by the German Association of Research-Based Pharmaceutical Companies (vfa).

Contact: Katja Standke, k.standke@vfa(dot)de

Associated programme online

Digital fundamental rights in the EU: A digital code of ethics for a new era

The event addresses the issue of the ethical, legal and social framework conditions for the use of health data. In view of the ongoing digital transformation in the health care system, a clear European idea is needed with regard to the conditions under which health data can be used for research purposes and to control and supervise the management of health care. To deal with the COVID-19 pandemic, there are digital data collection and evaluation methods available that concern ethical and data privacy regulations.  These potential conflicts and solutions for the optimal use of data require a thorough review and clarification. The aim of the event is therefore to focus on the examination of and solutions to cross-border problems in terms of the promotion of digital transformation in the health care system. The keynotes and discussions at the event present a contribution from a health insurance fund perspective on the reception of a "code of conduct". #EU2020TK

This event is public and organised by Techniker Krankenkasse (TK).

More Information: Die Techniker

Contact: eu2020@tk(dot)de

Events MoH presence

21st century challenges for the eHealth National Competence Centers in Europe

The event offers a special forum for the European competence centres for digital health to discuss current challenges and trends in the digitalisation of healthcare within Europe. The details of the event will be determined by the further development of the European eHealth Digital Service Infrastructure and the intensification of European cooperation in the area of technical standards and best practices for digital health. The event’s goal is to come together with European partners to elaborate a joint vision for a digital and cross-linked healthcare system in Europe.

This is a non-public event.

More Information: gematik (German)

Institutional programme online

Heads of Medicines Agencies (HMA) Meeting

The Heads of Medicines Agencies (HMA) is a network of the heads of the National Competent Authorities (NCA) whose organisations are responsible for the regulation of medicinal products for human and veterinary use in the European Economic Area.

They meet quarterly to discuss topics of strategic relevance together with representatives of the European Medicines Agency (EMA), the European Commission (EC) and the European Directorate for the Quality of Medicines (EDQM).

This event is  non-puplic and organized by the Federal Institute for Vaccines and Biomedicines.

Associated programme hybrid

To ensure the availability of medicine - a pan-European challenge

All Member States of the European Union discuss problems of ensuring the availability of medicines. The experience from the COVID-19 pandemic has increased the importance of these problems. This makes coordinated action at EU level more important. The German government put medicine shortages high on the agenda of its EU Council Presidency. The AOK, with over 26 million health-insured persons in Germany, will address these and other questions in a digital dialogue with representatives from German and European politics as well as from science. Speakers will be: Thomas Müller, head of department at the German Federal Ministery of Health on pharmaceutical and other issues, Jutta Paulus, Member of the European Parliament, Noel Wathion, Deputy Executive Director of the European Medicines Agency (EMA), Dr. Sabine Vogler, pharmaceutical economist at Gesundheit Österreich GmbH, Dr. Christa Wirthumer-Hoche, Austrian Medical Market Authority (AGES) and Martin Litsch, Chairman of the Federal Association of the AOK.

This event is puplic and organised by AOK-Bundesverband.

Contact: Tamara Marraffa, tamara.marraffa@bv.aok(dot)de

Events MoH online

Building genomics: genomDE - National and European initiatives

Genome sequencing is to be introduced into routine healthcare practice in Germany. The aim of the genome initiative “genomDE” is the use of clinical, phenotypic and genomic data in health care. New insights will flow into research. This knowledge-generating care concept is intended to elevate German health care to a new level. Furthermore, national activities will be connected with the European '1+ Million Genomes' Initiative. Both initiatives will be important for a common European data space. “genomDE” is part of the Federal Government’s Coalition Agreement, the HighTech Strategy 2025, the AI Strategy (2018) and the Data Strategy White Paper (2019), as well as the extensive digitalisation measures by the Federal Ministry of Health.The genome initiative “genomDE” will be presented in the context of national and European initiatives.

This is a non-public event.

Associated programme online

Medicines for Future – How to ensure availability and access

The conference will discuss with a strong involvement of the heads of European medicines agencies the major challenges for a sustainable supply of both prescription and non-prescription medicines as well as other consumer health products. Special attention will be paid to issues such as medicines‘ shortages, real world data but also to the switch of medicines from prescription to non-prescription status.  Overarching theme in all areas is digitalisation in health care.

This event is public and organised by the German Medicines Manufacturers' Association (BAH).

Contact: Friederike Gruner-Gramstadt, gruner@bah-bonn(dot)de

More Information: German Medicines Manufacturers' Association

Associated programme presence

Medicines shortages: Giving up? Finding solutions!

Medicines shortages have been part of everyday life in Europe for some years now. The reasons for this are complex and lie, for instance, in the structures of the highly globalised and specialised pharmaceutical production. For certain active ingredients there are currently only a few manufacturers worldwide. Loss of production or quality problems in a single plant could then be enough to endanger the supply of medicines to patients in Europe. The outbreak of the COVID-19 pandemic has now exacerbated this situation and ignited a new debate at EU level. Together with a high-level panel consisting of Members of the European Parliament, members of the European Commission and representatives of international pharmacists' associations and the pharmaceutical industry, ABDA - Federal Union of German Associations of Pharmacists would like to shed light on the challenges surrounding this problem and discuss possible solutions. #medicinesshortages

This event is public and organised by the Federal Union of German Associations of Pharmacists (ABDA).

Contact: Dr. Jens Gobrecht, europa@abda(dot)de

Events Brussels presence

Employment, Social Policy, Health and Consumer Affairs Council (EPSCO)

The Employment, Social Policy, Health and Consumer Affairs Council (EPSCO) of the EU ministers of health will meet in Brussels on 2 December 2020 at the invitation of German Federal Minister Jens Spahn. In the public health area, the Council adopts legislation on healthcare-related topics together with the EU Parliament while preserving the competences of each member state, e.g. with the aim of improving the health of EU citizens or EU rapid response capacities.

More Information: Employment, Social Policy, Health and Consumer Affairs Council configuration (EPSCO) (European Council)



Institutional programme online

Meeting of the Working Group of Communication Professionals (WGCP)

The Working Group of Communications Professionals (WGCP) was established in 2007 by the Heads of Medicines (HMA) to actively shape and expand communications expertise across the network. To this end, the WGCP shares good practice, coordinates communications across the HMA network in a crisis and helps develop and improve the HMA’s website. In addition, it fosters the professional communication between the HMA and its stakeholders (for instance patients, physicians, veterinarians, pharmaceutical industry, and other healthcare professionals) and the general public (including the media).

This event is non-puplic and organized by the Federal Institute for Drugs and Medical Devices.

More Information: Heads of Medicines Agencies (HMA)




Associated programme hybrid

BVMed Convention on Hygiene

The BVMed Hygiene Convention addresses important topics and issues in the field of hygiene and infection control in hospitals, nursing homes and other medical facilities. A pandemic such as the COVID-19 pandemic, which has affected the entire EU since early 2020, highlights the need for effective infection control. Strict adherence to basic preventive measures protects against the spread of infections and thus saves lives. In addition to this topic, this year's BVMed Hygiene Convention will focus on innovative, and in particular digital, support options in the EU: Which offers in the field of hygiene and infection protection are already available today? Where would digital offers be particularly useful? How can digital communication between sectors in the healthcare system ensure better care outcomes? Which innovative and alternative concepts – also within the professional field of the nurse – are there beyond that to effectively and efficiently implement infection control? #RechtaufHygiene

This event is public and organised by the German Medical Technology Association (BVMed).

Contact: Lena Geppert, geppert@bvmed(dot)de

More Information: bvmed